Screener
Bausch Health Companies BHC Noncontrolling interests in subsidiaries
Noncontrolling interests in subsidiaries at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept us-gaap:MinorityInterest.
The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.
- Filed
- Apr 29, 2026, 6:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885590-26-000053
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Common shares, no par value, unlimited shares authorized, 373,464,760 and 370,531,987 issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 10,542 | 10,516 |
| Additional paid-in capital | 295 | 357 |
| Accumulated deficit | (11,090) | (9,667) |
| Accumulated other comprehensive loss | (1,806) | (1,760) |
| Total Bausch Health Companies Inc. shareholders’ deficit | (2,059) | (554) |
| Noncontrolling interest | 977 | 931 |
| Total (deficit) equity | (1,082) | 377 |
| Total liabilities and equity | $24,498 | $26,366 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Bausch Health Companies's noncontrolling interests in subsidiaries?
- Bausch Health Companies (BHC) reported noncontrolling interests in subsidiaries of $977M in Q1 2026.
- How has Bausch Health Companies's noncontrolling interests in subsidiaries changed year-over-year?
- Bausch Health Companies's noncontrolling interests in subsidiaries increased by 3.6% year-over-year, from $943M to $977M.
- What is the long-term trend for Bausch Health Companies's noncontrolling interests in subsidiaries?
- Over 5 years (2020 to 2025), Bausch Health Companies's noncontrolling interests in subsidiaries has grown at a 67.8% compound annual growth rate (CAGR), from $70M to $931M.
- What does noncontrolling interests in subsidiaries mean?
- This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.
Ask your AI about Bausch Health Companies's noncontrolling interests in subsidiaries.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude